Home › Diffuse Scleroderma › New Jersey
Diffuse Scleroderma clinical trials in New Jersey
3 studies for Diffuse Scleroderma are looking for participants at sites in New Jersey.
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Astera Cancer Care, East Brunswick
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104Platform Clinical Study for Conquering Scleroderma
- Robert Wood Johnson Medical School, New Brunswick
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Hackensack
- Nkarta Investigational Site, Summit
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Aug 7, 2026 · NCT06733935From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.